HHS to Fund $4.9 Million Research Program on Ibogaine for PTSD Treatment
Source Summary
The Trump administration's Department of Health and Human Services will allocate up to $4.9 million to fund research into ibogaine, a psychedelic compound being investigated as a potential treatment for post-traumatic stress disorder and addiction. The funding represents a government commitment to exploring psychedelic-assisted therapies for mental health conditions.
Why it matters
Federal funding for ibogaine research signals government recognition of psychedelic compounds as legitimate candidates for treating serious mental health conditions with limited existing options.
